OrCam device

Last updated

OrCam
Company type Private company
Industry Health, Assistive technology
Founded2010;14 years ago (2010)
Jerusalem
FounderZiv Aviram
Amnon Shashua
Headquarters
Har Hotzvim, Jerusalem, Israel
Key people
Prof Amnon Shashua
(Chairman and CTO) Ziv Aviram
(President and CEO) Dr. Yonatan Wexler
(Executive VP of R&D)
ProductsOrCam MyEye and OrCam MyReader
Number of employees
394 (2021)
Website http://www.orcam.com/

OrCam devices such as OrCam MyEye are portable, artificial vision devices that allow visually impaired people [1] to understand text and identify objects through audio feedback, describing what they are unable to see.

Contents

Reuters described an important part of how it works as "a wireless smartcamera" which, when attached outside eyeglass frames, can read and verbalize text, and also supermarket barcodes. This information is converted to spoken words and entered "into the user’s ear." Face-recognition [2] is also part of OrCam's feature set. [3]

Devices

OrCam Technologies Ltd has created three devices; OrCam MyEye 2.0, OrCam MyEye 1, and OrCam MyReader.

OrCam My Eye 2.0:

OrCam MyEye 2.0 OrCam155.jpg
OrCam MyEye 2.0

Clinical Studies

JAMA Ophthalmology: In 2016 JAMA Ophthalmology conducted a study involving 12 legally blind participants to evaluate the usefulness of a portable artificial vision device (OrCam) for patients with low vision. The results showed that the OrCam device improved the patient's ability to perform tasks simulating those of daily living, such as reading a message on an electronic device, a newspaper article or a menu. [5]

Wills Eye: Wills Eye was a clinical study designed to measure the impact of the OrCam device on the quality of life of patients with End-stage Glaucoma. The conclusion was that OrCam, a novel artificial vision device using a mini-camera mounted on eyeglasses, allowed legally blind patients with end-stage glaucoma to read independently, subsequently improving their quality of life. [6]

OrCam90 OrCam90.jpg
OrCam90

Employee testing

The New York Times described how a pre-release OrCam device was used by a Coloboma-impaired employee of the device's developer in 2013 [7] for grocery shopping. It was the small size of the prototype rather than the functionality that gave her added mobility in an Israeli store's aisles.[ citation needed ]

Added life-enhancement was described: "to both recognize and speak .. bus numbers .. traffic lights." [7]

Social aspects

In contrast to an early version of Google Glass, which "failed ... because .. Glass wearers were ..mocked", [8] early OrCam devices used designs that "clip unobtrusively on your shirt or perhaps your belt." [8]

In addition, it does not record sounds or images, what was called "the privacy puzzle that stumped Google. [8]

One 2018 technology reviewer wrote that he wished it had a headphone jack "so it would be less disruptive in places where others are working." [9] An attempt was made to use bone conduction. [10]

USA introduction

In 2018 a team headed by New York Assemblyman Dov Hikind introduced use of OrCam devices to ten individuals screened for what he termed "new Israeli technology that really makes a difference to the blind." [11]

Although not the first USA success, it was more focused than a publicly funded project that was authorized in 2016 by a California government agency. [12] [13] Also in 2016 the Chicago Lighthouse for the Blind demonstrated its use. [14]

Technology

In the area of hardware, miniaturization has been quite important, but one major area, software, was mentioned by Assemblyman Hikind, and reported by The Times of Israel [15] is the "AI-driven algorithms" that "reports .. how many people are in a room. [16]

In addition to reading printed text, it can also aid in "seeing" what is on a television or computer screen. [17] Although OrCam can't help with handwritten information, [18] it can reuse information, the basis of recognizing "US currency, and even faces." [19] [2]

Features

While early language support was for English, French, German, Hebrew and Spanish, [18] others now available include Danish, Dutch, Finnish, Italian, Norwegian, Portuguese and Swedish.

History

OrCam Technologies Ltd was founded in 2010 by Professor Amnon Shashua and Ziv Aviram. Before co-founding OrCam, the two in 1999 co-founded Mobileye, an Israeli company that develops vision-based advanced driver-assistance systems (ADAS) providing warnings for collision prevention and mitigation, which was acquired by Intel for $15.3 billion in 2017. OrCam launched OrCam MyEye in 2013 after years of development and testing, and began selling it commercially in 2015. [20]

In its early years, the company raised $22 million, $6 million of which came from Intel Capital. By 2014, Intel, which was also investing in Google Glass, had invested $15 million in Orcam. [21] In March 2017, OrCam had raised $41 million in capital, making it worth $600 million. [22]

Marketing

One outcome of initial marketing in the USA was that they "reached a deal with the California Department of Rehabilitation, ...qualifying blind and visually impaired state residents." [12]

OrCam Technologies Ltd

OrCam Technologies Ltd. is the Israeli-based company producing these OrCam devices, which are wearable artificial intelligence space. The company develops and manufactures assistive technology devices for individuals who are visually impaired, partially sighted, blind, print disabilities, or have other disabilities. OrCam headquarters is located in Jerusalem, operating under the company name OrCam Technologies Ltd.

OrCam has over 150 employees, is headquartered in Jerusalem, [23] and has offices in New York, Toronto, and London.

Awards

Related Research Articles

<span class="mw-page-title-main">Glaucoma</span> Group of eye diseases

Glaucoma is a group of eye diseases that lead to damage of the optic nerve, which transmits visual information from the eye to the brain. Glaucoma may cause vision loss if left untreated. It has been called the "silent thief of sight" because the loss of vision usually occurs slowly over a long period of time. A major risk factor for glaucoma is increased pressure within the eye, known as intraocular pressure (IOP). It is associated with old age, a family history of glaucoma, and certain medical conditions or medications. The word glaucoma comes from the Ancient Greek word γλαυκóς, meaning 'gleaming, blue-green, gray'.

The National Eye Institute (NEI) is part of the U.S. National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services. The mission of NEI is "to eliminate vision loss and improve quality of life through vision research." NEI consists of two major branches for research: an extramural branch that funds studies outside NIH and an intramural branch that funds research on the NIH campus in Bethesda, Maryland. Most of the NEI budget funds extramural research.

The visual field is "that portion of space in which objects are visible at the same moment during steady fixation of the gaze in one direction"; in ophthalmology and neurology the emphasis is on the structure inside the visual field and it is then considered “the field of functional capacity obtained and recorded by means of perimetry”.

<span class="mw-page-title-main">Cataract surgery</span> Removal of opacified lens from the eye

Cataract surgery, also called lens replacement surgery, is the removal of the natural lens of the eye that has developed a cataract, an opaque or cloudy area. The eye's natural lens is usually replaced with an artificial intraocular lens (IOL) implant.

TheChicago Lighthouse is a non-profit organization located in Chicago, Illinois.

<span class="mw-page-title-main">Visual impairment</span> Decreased ability to see

Visual or vision impairment is the partial or total inability of visual perception. For the former and latter case, the terms low vision and blindness respectively are often used. In the absence of treatment such as corrective eyewear, assistive devices, and medical treatment – visual impairment may cause the individual difficulties with normal daily tasks including reading and walking. In addition to the various permanent conditions, fleeting temporary vision impairment, amaurosis fugax, may occur, and may indicate serious medical problems.

Braille technology is assistive technology which allows blind or visually impaired people to read, write, or manipulate braille electronically. This technology allows users to do common tasks such as writing, browsing the Internet, typing in Braille and printing in text, engaging in chat, downloading files and music, using electronic mail, burning music, and reading documents. It also allows blind or visually impaired students to complete all assignments in school as the rest of their sighted classmates and allows them to take courses online. It enables professionals to do their jobs and teachers to lecture using hardware and software applications. The advances in Braille technology are meaningful because blind people can access more texts, books, and libraries, and it also facilitates the printing of Braille texts.

<span class="mw-page-title-main">Mobileye</span> Israeli information technology company

Mobileye Global Inc. is an Israeli autonomous driving company. It is developing autonomous driving technologies and advanced driver-assistance systems (ADAS) including cameras, computer chips, and software. Mobileye was acquired by Intel in 2017 and went public again in 2022.

Yissum Research Development Company is the technology transfer company of the Hebrew University of Jerusalem. Founded in 1964, it is the third tech transfer company in the world to be created, and seeks to convert research into commercial solutions.

José-Alain Sahel is a French ophthalmologist and scientist. He is currently the chair of the Department of Ophthalmology at the University of Pittsburgh School of Medicine, director of the UPMC Eye Center, and the Eye and Ear Foundation Chair of Ophthalmology. Dr. Sahel previously led the Vision Institute in Paris, a research center associated with one of the oldest eye hospitals of Europe - Quinze-Vingts National Eye Hospital in Paris, founded in 1260. He is a pioneer in the field of artificial retina and eye regenerative therapies. He is a member of the French Academy of Sciences.

The Vision Institute is a research center in the Quinze-Vingts National Eye Hospital in Paris, France. It is one of several such centers in Europe on eye diseases.

<span class="mw-page-title-main">Childhood blindness</span> Medical condition

Childhood blindness is an important contribution to the national prevalence of the disability of blindness. Blindness in children can be defined as a visual acuity of <3/60 in the eye with better vision of a child under 16 years of age. This generally means that the child cannot see an object 10 feet away, that another child could see if it was 200 feet away.

<span class="mw-page-title-main">Amnon Shashua</span> Israeli computer scientist and businessman

Amnon Shashua is an Israeli computer scientist and businessman. He is the Sachs Professor of Computer Science at the Hebrew University of Jerusalem, president and chief executive officer (CEO) of the autonomous driving and driver-assistance technology company Mobileye, Co-founder of the artificial vision devices company OrCam, Founder and owner of ONE ZERO digital bank, and chairman of artificial intelligence company AI21 Labs.

<span class="mw-page-title-main">Alex Deans</span> Canadian-British inventor

Alexander Deans is a Canadian-British inventor, engineer, and physician. He became Her Majesty Queen Elizabeth II's Youth Leader for Canada at Buckingham Palace. At age 12, he created the "iAid", a navigation device for the blind which won the Canada-Wide Science Fair in the intermediate category and several awards at the 2014 Intel International Science and Engineering Fair.

CloudSight, Inc. is a Los Angeles, CA-based technology company that specializes in image captioning, and understanding.

eSight is a wearable medical device designed to improve the functional vision of those living with low vision or legal blindness. The device was developed by Canadian-based company eSight Corp.

Seeing AI is an artificial intelligence application developed by Microsoft for iOS. Seeing AI uses the device camera to identify people and objects, and then the app audibly describes those objects for people with visual impairment.

<span class="mw-page-title-main">Yoav Chelouche</span> Israeli businessman

Yoav Z. Chelouche is an Israeli businessman, a managing partner of Tel Aviv-based venture capital firm Aviv Venture Capital. In 1995–2001, Chelouche served as CEO and President of Scitex Corporation. He sits on the board of directors of the Tel Aviv Stock Exchange (TASE), Tower Semiconductor (Towerjazz) and Check Point Software Technologies., and was co-chairman of Israel Advanced Technology Industries (IATI).

ScripTalk is an audible medication label technology designed to give access to individuals who are blind, visually impaired, or print impaired. It consists of a device and a microchip attached to the bottom of a prescription drug bottle. The label information is encoded on a Radio-frequency identification (RFID) electronic label (microchip) using the ScriptAbility software by a pharmacist and placed on the prescription package. ScripTalk prescription labels were introduced in the early 2000s. As of 2020, the technology was applied through the United States and Canada.

<span class="mw-page-title-main">Ziv Aviram</span> Israeli CEO and founder of Mobileye

Ziv Aviram is an Israeli businessman, investor, manager of several global companies, and Philanthropist, Founder and President of Aviram Foundation, co-founder, co-chairman of OrCam Technologies, and co-founder of Mobileye.

References

  1. ↑ The NYTimes article headlined "Simple Home Improvements for the Vision Impaired" (https://www.nytimes.com/2018/04/13/realestate/simple-home-improvements-for-the-vision-impaired.html) uses twice the words "visually impaired"
  2. 1 2 Romain Dillet (July 12, 2017). "The OrCam MyEye helps visually impaired people read and identify things". techcrunch.com. Retrieved February 8, 2018.
  3. ↑ "Israeli visual aid company OrCam valued at $1 billion". Reuters . February 19, 2018.
  4. ↑ "New device gives people with vision problems a second chance at sight". CBSLocal.com (CBS, New York). December 6, 2017.
  5. ↑ "Portable Artificial Vision Device May Be an Effective Aid for Patients with Low Vision - For The Media - JAMA Network". media.jamanetwork.com.
  6. ↑ Waisbourd, Michael; Ahmed, Osama; Siam, Linda; Moster, Marlene R.; Hark, Lisa A.; Katz, L. Jay (June 11, 2015). "The Impact of a Novel Artificial Vision Device (OrCam) on the Quality of Life of Patients with End-Stage Glaucoma". Investigative Ophthalmology & Visual Science. p. 519.
  7. 1 2 John Markoff (June 3, 2013). "Device From Israeli Start-Up Gives the Visually Impaired a Way to Read". The New York Times .
  8. 1 2 3 John Markoff (December 31, 2015). "It's an Unobtrusive Assistant Whispering in Your Ear (Not Little Brother)". The New York Times .
  9. ↑ Michael J. Miller (January 5, 2018). "OrCam MyEye Brings New Features to Visually Impaired". PC Magazine .
  10. ↑ Bill Holton (February 2017). "MyReader and MyEye from OrCam: Text and Item Recognition at the Touch of a Finger". AccessWorld. American Foundation for the Blind. Archived from the original on December 24, 2018. Retrieved December 24, 2018.
  11. ↑ "10 blind individuals gifted $35K in Hi-Tech "seeing" devices, Life-Changing Isaeli Tech changes lives, thanks to anonymous donor. Hikind: "It's a modern-day miracle!"". November 11, 2018. Archived from the original on January 29, 2020. Retrieved December 24, 2018.
  12. 1 2 Ruth Eglash (May 21, 2016). "Could a new smart cam designed for the blind help my dyslexic daughter?". The Washington Post .
  13. ↑ a year later it was still (just) authorized, but none were actually distributed: "Technology for the Blind". June 1, 2017.
  14. ↑ Hosea Sanders (April 24, 2016). "For the visually impaired, a technological breakthrough". ABC7chicago.com.
  15. ↑ Urvashi Verma (February 20, 2018). "OrCam raises $30.4 million, bringing startup to $1 billion valuation". The Times of Israel .
  16. ↑ Hikind report, Winter 2018 edition
  17. ↑ Bruce Sterling. "Augmented Reality: OrCam". Wired. Retrieved February 8, 2018.
  18. 1 2 "OrCam - A Point of Seeing". Ability Magazine.
  19. ↑ "MyReader and MyEye from Orcam: Text and Item Recognition". AFB.org (American Federation for the Blind).
  20. ↑ Vision Aware
  21. ↑ Eric Van Susteren (March 27, 2014). "Intel Capital invests in OrCam, Google Glass for the visually impaired". Silicon Valley Business Journal.
  22. ↑ "After sale to Intel, Mobileye's founder raises sights on IPO for OrCam". Reuters. March 30, 2017. Retrieved February 8, 2018.
  23. ↑ Webster, Sophie (January 7, 2022). "OrCam's MyEye Pro Device on Glasses Can Help Visually Impaired Users to Read".
  24. ↑ "Last Gadget Standing". lastgadgetstanding.com. Archived from the original on January 29, 2020. Retrieved February 13, 2018.
  25. ↑ "CES Tech Events". ces.tech. Retrieved February 8, 2018.
  26. ↑ "Naidex". Naidex. Retrieved February 8, 2018.
  27. ↑ "THE 56TH ANNUAL LOUIS BRAILLE AWARDS - Associated Services for the Blind & Visually Impaired". Archived from the original on February 14, 2018. Retrieved February 13, 2018.
  28. ↑ "Winners 2016". en.silmoparis.com. Archived from the original on February 8, 2018. Retrieved February 8, 2018.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.